Stem cell enrichment with selectin receptors: Mimicking the pH environment of trauma

Sensors (Switzerland)

Volumn 13, Issue 9, 2013, Pages 12516-12526

  Cao, Thong M ^a   Mitchell, Michael J ^a   Liesveld, Jane ^b   King, Michael R ^a  

^a School of Operations Research and Industrial Engineering   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Acidic pH; Biomimetic; L selectin

Indexed keywords

BIOMIMETICS; MOLECULAR DYNAMICS;

ACIDIC PH; BIOMIMETIC DEVICES; CONFORMATIONAL CHANGE; HEMATOPOIETIC STEM CELLS; ISOLATION TECHNIQUES; L-SELECTIN; MICROENVIRONMENTS; TRANSPLANTATION THERAPY;

STEM CELLS;

EID: 84884405366     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s130912516     Document Type: Article

References (40)

1. Ogawa, M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993, 81, 2844-2853.
2. Kondo, M.; Wagers, A.J.; Manz, M.G.; Prohaska, S.S.; Scherer, D.C.; Beilhack, G.F.; Shizuru, J.A.; Weissman, I.L. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 2003, 21, 759-806.
3. Dey, B.R.; Shaffer, J.; Yee, A.J.; McAfee, S.; Caron, M.; Power, K.; Ting, D.T.; Colby, C.; Preffer, F.; Ballen, K.; et al. Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen. Bone Marrow Trans. 2007, 40, 19-27.
4. Dodero, A.; Carniti, C.; Raganato, A.; Vendramin, A.; Farina, L.; Spina, F.; Carlo-Stella, C.; Di Terlizzi, S.; Milanesi, M.; Longoni, P.; et al. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: Posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. Blood 2009, 113, 4771-4779.
5. Chu, S.H.; Heiser, D.; Li, L.; Kaplan, I.; Collector, M.; Huso, D.; Sharkis, S.J.; Civin, C.; Small, D. FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, leading to Myeloproliferative Neoplasm. Cell Stem Cell 2012, 11, 346-358.
6. Zhang, Y.; Yan, X.; Sashida, G.; Zhao, X.; Rao, Y.; Goyama, S.; Whitman, S.P.; Zorko, N.; Bernot, K.; Conway, R.M.; et al. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Blood 2012, 120, 1118-1129.
7. Orkin, S.H.; Zon, L.I. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008, 132, 631-644.
8. Gordon, M.Y. Adhesive properties of haemopoietic stem cells. Br. J. Haematol. 1988, 68, 149-151.
9. Wright, D.E. Physiological migration of hematopoietic stem and progenitor cells. Science 2001, 294, 1933-1936.
10. Fleming, W.H.; Alpern, E.J.; Uchida, N.; Ikuta, K.; Weissman, I.L. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. USA 1993, 90, 3760-3764.
11. Smith, A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 2001, 17, 435-462.
12. Laird, D.J.; von Andrian, U.H.; Wagers, A.J. Stem cell trafficking in tissue development, growth, and disease. Cell 2008, 132, 612-630.
13. Müller, A.M.; Medvinsky, A.; Strouboulis, J.; Grosveld, F.; Dzierzakt, E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994, 1, 291-301.
14. Massberg, S.; Schaerli, P.; Knezevic-Maramica, I.; Köllnberger, M.; Tubo, N.; Moseman, E.A.; Huff, I.V.; Junt, T.; Wagers, A.J.; Mazo, I.B.; et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131, 994-1008.
15. Lee, H.; Ratajczak, M.Z. Innate immunity: A key player in the mobilization of hematopoietic stem/progenitor cells. Arch. Immunol Ther. Exp. 2009, 57, 269-278.
16. Ratajczak, M.Z.; Kim, C.H.; Wojakowski, W.; Janowska-Wieczorek, A.; Kucia, M.; Ratajczak, J. Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010, 24, 1667-1675.
17. Mitchell, M.J.; King, M.R. Computational and experimental models of cancer cell response to fluid shear stress. Front. Oncol. 2013, 3, 1-11.
18. Mitchell, M.J.; King, M.R. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors. New J. Phys. 2013, 15, 015008.
19. Dimitroff, C.J. Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J. Biolog. Chem. 2001, 276, 47623-47631.
20. Merzaban, J.S.; Burdick, M.M.; Gadhoum, S.Z. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood 2011, 118, 1774-1783.
21. Sultana, D.A.; Zhang, S.L.; Todd, S.P.; Bhandoola, A. Expression of functional P-selectin glycoprotein ligand 1 on hematopoietic progenitors is developmentally regulated. J. Immunol. 2012, 188, 4385-4393.
22. Narasipura, S.D.; Wojciechowski, J.C.; Charles, N.; Liesveld, J.L.; King, M.R. P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. Clin. Chem. 2008, 54, 77-85.
23. Mitchell, M.J.; King, M.R. Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys. J. 2012, 102, 1804-1814.
24. Cao, T.M.; Takatani, T.; King, M.R. Effect of extracellular pH on selectin adhesion: Theory and experiment. Biophys. J. 2013, 104, 292-299.
25. Trevani, A.S.; Andonegui, G.; Giordano, M.; López, D.H.; Gamberale, R.; Minucci, F.; Geffner, J.R. Extracellular acidification induces human neutrophil activation. J. Immunol. 1999, 162, 4849-4857.
26. Lardner, A. The effects of extracellular pH on immune function. J. Leukoc. Biol. 2001, 69, 522-530.
27. Cook, D.N. The role of MIP-1 alpha in inflammation and hematopoiesis. J. Leukoc. Biol. 1996, 59, 61-66.
28. Mourkioti, F.; Rosenthal, N. IGF-1, inflammation and stem cells: Interactions during muscle regeneration. Trend. Immunol. 2005, 26, 535-542.
29. Amselem, S.; Cohen, R.; Druckmann, S.; Gabizon, A.; Goren, D.; Abra, R.M.; Huang, A.; New, R.; Barenholz, Y. Preparation and characterization of liposomal doxorubicin for human use. J. Liposome Res. 1992, 2, 93-123.
30. Haran, G.; Cohen, R.; Bar, L.; Barenholz, Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1993, 1151, 201-215.
31. Mitchell, M.J.; Chen, C.S.; Ponmudi, V.; Hughes, A.D.; King, M.R. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J. Contr. Release 2012, 160, 609-617.
32. Mitchell, M.J.; Castellanos, C.A.; King, M.R. Nanostructured surfaces to target and kill circulating tumor cells while repelling leukocytes. J. Nanomater. 2012, 2012, 1-10.
33. Huang, Z.; King, M. An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation. Gene Therapy 2009, 16, 1271-1282.
34. Lawrence, M.B.; Springer, T.A. Neutrophils roll on E-selectin. J. Immunol. 1993, 151, 6338-6346.
35. Bevilacqua, M.P.; Nelson, R.M. Selectins. Clin. Invest. 1993, 91, 379-387.
36. Greenberg, A.W.; Kerr, W.G.; Hammer, D.A. Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood 2000, 95, 478-486.
37. Phan, U.T.; Waldron, T.T.; Springer, T.A. Remodeling of the lectin-EGF-like domain interface in P-and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat. Immunol. 2006, 7, 883-889.
38. Wojciechowski, J.; Narasipura, S.; Charles, N.; Mickelsen, D.; Rana, K.; Blair, M.; King, M. Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device. Br. J. Hematol. 2008, 140, 673-681.
39. Charles, N.; Liesveld, J.L.; King, M.R. Investigating the feasibility of stem cell enrichment mediated by immobilized selectins. Biotechnol. Prog. 2007, 23, 1463-1472.
40. Hughes, A.D.; Mattison, J.; Powderly, J.D.; Greene, B.T.; King, M.R. Rapid isolation of viable circulating tumor cells from patient blood samples. JoVE 2012, 64, e4248-e4248.